Achieve Life Sciences ACHV Stock options excluded as their inclusion would be anti-dilutive (in shares)
Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.
The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's stock options excluded as their inclusion would be anti-dilutive (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Achieve Life Sciences (ACHV) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 26.6M in Q1 2026.
- How has Achieve Life Sciences's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
- Achieve Life Sciences's stock options excluded as their inclusion would be anti-dilutive (in shares) increased by 17.2% year-over-year, from 22.7M to 26.6M.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- This metric quantifies the number of potential common shares, such as stock options or convertible instruments, that are excluded from the diluted earnings per share calculation because their inclusion would increase earnings per share or decrease the loss per share. These securities are considered anti-dilutive under current market conditions. Tracking this helps investors understand the potential future dilution that could occur if market prices rise above the exercise or conversion thresholds.